Add to wishlist

Current Concepts in Hematopathology 2022 (Videos)

$50.00

Format: 37 Videos + 2 PDFs

Category:

Posted By: Dr_magic

0 Rating

published date: 17 Aug 22

In this online CME program, leaders in diagnostic pathology deliver in-depth discussions of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. Current Concepts in Hematopathology delivers continuing medical education insights, including:

  • common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations
  • approaches to cases that do not conform to WHO diagnostic categories
  • use of evidence-based guidelines, cytogenetics, and molecular testing to inform diagnosis

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies
  • Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms
  • Diagnose challenging cases that do not readily conform to well-established entities
  • Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy

Target Audience

This course is targeted to specialty physicians who practice in pathology.

TOPICS / SPEAKERS

Nodal Small B-Cell Lymphomas - Elizabeth A. Morgan, MD

Plasma Cell Neoplasms and Lymphoplasmacytic Lymphoma - Valentina Nardi, MD

Question & Answer - Robert P. Hasserjian, MD - Moderator, Elizabeth A. Morgan, MD and Valentina Nardi, MD

Immunodeficiency and Viral-Associated Lymphoproliferations - Judith A. Ferry, MD

Updates in Cutaneous Lymphomas - Sam Sadigh, MD

Question & Answer - Elizabeth A. Morgan, MD - Moderator, Judith A. Ferry, MD and Sam Sadigh, MD

WHO Update - Follicular Lymphoma and Related Entities - Abner Louissaint Jr., MD, PhD

Diffuse Large B-Cell Lymphoma Subtypes - Scott B. Lovitch, MD, PhD

Question & Answer - Marian H. Harris, MD - Moderator, Abner Louissaint Jr, MD, PhD and Scott B. Lovitch, MD, PhD

Burkitt Lymphoma and High-Grade B-Cell Lymphomas – A Practical Guide and Update - Aliyah R. Sohani, MD

Reactive Lymphadenopathies and Castleman Disease - Yasodha Natkunam, MD, PhD

Question & Answer - Robert P. Hasserjian, MD - Moderator, Yasodha Natkunam, MD, PhD and Aliyah R. Sohani, MD

Approach to Peripheral Smear Review - Elizabeth Courville, MD

Myelodysplastic Syndrome and Its Differential Diagnosis - Robert P. Hasserjian, MD

Question & Answer - Elizabeth A. Morgan, MD - Moderator, Elizabeth Courville, MD and Robert P. Hasserjian, MD

Acute Myeloid Leukemia and Acute Leukemias of Ambiguous Lineage - Olga K. Weinberg, MD

Acute Lymphoblastic Leukemia - Marian H. Harris, MD, PhD

Question & Answer - Robert P. Hasserjian, MD - Moderator, Marian H. Harris, MD, PhD and Olga K. Weinberg, MD

Eosinophilia and Mastocytosis - Olga Pozdnyakova, MD, PhD

Myelodysplastic/Myeloproliferative Neoplasms - Robert P. Hasserjian, MD

Question & Answer - Marian H. Harris, MD, PhD - Moderator, Robert P. Hasserjian, MD and Olga Pozdnyakova, MD, PhD

Interpreting Flow Cytometry Minimal Residual Disease in Acute Leukemia - Sa A. Wang, MD

Practical Interpretation of Molecular Testing in Myeloid Neoplasms - Annette S. Kim, MD, PhD

Question & Answer - Elizabeth A. Morgan, MD - Moderator, Annette S. Kim, MD, PhD and Sa A. Wang, MD

Challenges in the Diagnosis of Hodgkin Lymphomas - Marian H. Harris, MD, PhD

Primary Mediastinal Large B-Cell and Grey-Zone Lymphomas - Scott J. Rodig, MD, PhD

Question & Answer - Robert P. Hasserjian, MD - Moderator, Marian H. Harris, MD, PhD and Scott J. Rodig, MD, PhD

Indolent T-Cell Disorders - Kathleen H. Burns, MD, PhD

Nodal T-Cell Lymphomas - Roberto Chiarle, MD

Question & Answer - Marian H. Harris, MD, PhD - Moderator, Kathleen H. Burns, MD, PhD and Roberto Chiarle, MD

Histiocytic and Dendritic Cell Neoplasms - Elizabeth A. Morgan, MD

IgG4-Related Disease and Lymphadenopathy - Jacob R. Bledsoe, MD

Blastic Plasmacytoid Dendritic Cell Neoplasm - Gabriel K. Griffin, MD

Question & Answer - Marian H. Harris, MD, PhD - Moderator, Jacob R. Bledsoe, MD, Gabriel K. Griffin, MD and Elizabeth A. Morgan, MD

Inherited Predisposition to Myeloid (and Hematological) Malignancies - Mark D. Fleming, MD, DPhil

Spleen Pathology - Lawrence R. Zukerberg, MD

Question & Answer - Elizabeth A. Morgan, MD - Moderator, Mark D. Fleming, MD, DPhil and Lawrence R. Zukerberg, MD

Date of Original Release: June 30, 2022

Termination Date: June 30, 2025